Overview

Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the therapeutic effect of Liraglutide on autoimmune diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Second Xiangya Hospital of Central South University
Treatments:
Insulin
Insulin, Globin Zinc
Liraglutide